Chief Scientific Officer,Numerate
John Griffin is Chief Scientific Officer at Numerate, which has developed and applies an AI-driven approach to small molecule drug design. He was formerly Co-Founder and Chief Scientific Officer of Theravance and Assistant Professor of Chemistry at Stanford. John is the author of 39 publications, an inventor of 27 issued patents, and the recipient of awards including a Cope Scholar Award from the ACS and a Dean’s Award for Teaching from Stanford University. John received a B.S. in Chemistry from Hope College, a Ph.D. in Chemistry from Caltech and was a Postdoctoral Fellow at Harvard Medical School.